[Blocking of T-type calcium channels: new horizons in the therapeutic potential of calcium antagonists].
Cerqueira-Gomes
M
M
Maciel
M J
MJ
Martins
L
L
D001562:Benzimidazoles / Q000494:pharmacology*; D002121:Calcium Channel Blockers / Q000494:pharmacology*; D015220:Calcium Channels / Q000145:classification / Q000187:drug effects* / Q000502:physiology; D006339:Heart Rate / Q000187:drug effects; D006801:Humans; D020748:Mibefradil; D009200:Myocardial Contraction / Q000187:drug effects; D013764:Tetrahydronaphthalenes / Q000494:pharmacology*; D014665:Vasodilator Agents / Q000494:pharmacology*
D001562:Benzimidazoles; D002121:Calcium Channel Blockers; D015220:Calcium Channels; D013764:Tetrahydronaphthalenes; D014665:Vasodilator Agents; D020748:Mibefradil